Distinctive Cytogenetic Profile in Benign Metastasizing Leiomyoma: Pathogenetic Implications
Marisa R. Nucci(Brigham and Women's Hospital), Jonathan A. Fletcher(Harvard University), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Ronny Drapkin(University of Pennsylvania), Paola Dal Cin(Brigham and Women's Hospital)
Cited by 115
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716